MFDS
- Status: likely_approved
🇰🇷 Oxervate in South Korea
Oxervate (CENEGERMIN) regulatory status in South Korea.
Marketing authorisation
Oxervate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Oxervate approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Oxervate in South Korea?
Dompe farmaceutici s.p.a. is the originator. The local marketing authorisation holder may differ — check the official source linked above.